Japan Ophthalmic Viscoelastic Devices Market Overview - 2033
The Japan ophthalmic viscoelastic devices market size was valued at $0.18 billion in 2023 and is projected to reach $0.30 billion by 2033, registering a CAGR of 5.2% from 2024 to 2033. The growth of the Japan ophthalmic viscoelastic devices market is driven by rise in ophthalmic surgery cases. For instance, according to an article published in National Library of Medicine, there were 249,176 number of ophthalmological surgeries performed in 2021, where the proportion of cataract surgeries increased and accounting for 44.6% of the total ophthalmological surgeries.
Ophthalmic viscoelastic devices (OVDs) are essential tools used in eye surgery, particularly in cataract, corneal, and glaucoma procedures. These devices contain a gel-like substance that is injected into the eye to protect and maintain eye structures during surgery. OVDs help to stabilize the anterior chamber, protect the corneal endothelium, and create space for surgical maneuvers. By providing a clear and stable environment, OVDs enhance the surgeon's ability to perform delicate operations with precision and safety. They play a critical role in ensuring successful surgical outcomes and minimizing postoperative complications.
Key Takeaways
- On the basis of product, the cohesive OVD segment dominated the Japan ophthalmic viscoelastic devices market share in 2023. However, the dispersive OVD segment is anticipated to grow at the highest CAGR during the forecast period.
- On the basis of application, the cataract surgery segment dominated the market share in 2023. However, the glaucoma surgery segment is anticipated to grow at the highest CAGR during the forecast period.
- On the basis of end user, the hospitals segment dominated the market share in 2023. However, the ophthalmic clinics segment is anticipated to grow at the highest CAGR during the forecast period.
Market Dynamics
The growth of the ophthalmic viscoelastic devices market in Japan is propelled by a multifaceted interplay of factors, reflecting the country's technological prowess, demographic dynamics, disease epidemiology, healthcare infrastructure, market dynamics, and government support. This comprehensive ecosystem underscores Japan's position as a key player in the global ophthalmic industry and highlights the complex interdependencies shaping the market landscape.
Technological advancements stand at the forefront of driving growth in the Japan ophthalmic viscoelastic devices market. Japan is renowned for its innovative prowess, particularly in the medical field, where cutting-edge technologies continually push the boundaries of surgical precision and patient outcomes. In the ophthalmic sector, these advancements translate into the development of superior OVDs that offer enhanced viscosity, improved protective qualities, and ease of use during surgical procedures. Advanced formulations have led to the creation of cohesive and dispersive OVDs tailored to specific surgical needs, revolutionizing cataract and vitreoretinal surgeries. These innovations not only enhance surgical efficiency but also reduce the risk of complications, driving demand for these devices.
Moreover, Japan's aging population plays a pivotal role in fueling the demand for OVDs. With one of the highest proportions of elderly individuals globally, Japan faces a demographic shift characterized by a substantial segment of its population aged 65 and above. This demographic trend correlates with an increased prevalence of age-related eye conditions such as cataracts, glaucoma, and age-related macular degeneration (AMD). As these conditions necessitate surgical interventions, OVDs become indispensable tools in maintaining surgical efficacy and patient safety. The aging population thus generates a sustained demand for ophthalmic surgeries and, consequently, for OVDs.
Furthermore, the rising incidence of various eye diseases contributes to the expanding market for OVDs in Japan. Conditions such as diabetic retinopathy, linked to the growing rates of diabetes, and other ocular pathologies require intricate surgical procedures where OVDs play a critical role in maintaining the eye's structure and protecting delicate tissues. For example, glaucoma, a prevalent eye disease in Japan with an estimated prevalence of approximately 8%, poses significant challenges due to its association with aging and other non-ocular risk factors like diabetes. As the number of eye disease cases increases, the demand for effective surgical tools, including OVDs, grows correspondingly.
Japan's robust healthcare infrastructure significantly supports the growth of the OVDs market. The country's healthcare system is renowned for its high standards, comprehensive coverage, and advanced medical technologies. Hospitals and clinics are well-equipped with state-of-the-art facilities, enabling the performance of complex ophthalmic surgeries that rely on OVDs. This infrastructure ensures that patients have access to the latest treatments and surgical advancements, facilitating the adoption of OVDs and driving market expansion.
However, despite these favorable conditions, the Japan ophthalmic viscoelastic devices market faces significant challenges, including high costs and competitive pressures. Advanced OVDs and related ophthalmic surgical procedures come with substantial expenses, making them less accessible to a broader patient base. This financial barrier is particularly challenging for patients without comprehensive insurance coverage, limiting overall market demand. Additionally, the presence of numerous local and international players intensifies competition, leading to price wars and margin pressures. Companies struggle to differentiate their products and maintain market share, impacting profitability and market expansion. These challenges necessitate strategic pricing, enhanced product differentiation, and cost-effective innovations to sustain growth in Japan's competitive OVD market.
Government initiatives and support play a vital role in driving Japan ophthalmic viscoelastic devices market growth. The Japanese government actively funds research and development in the healthcare sector, encouraging innovation and the introduction of new medical products. Policies providing financial incentives and subsidies for healthcare advancements create a conducive environment for developing and adopting advanced OVDs. Additionally, government programs aimed at improving eye health and preventing ocular diseases enhance public awareness and encourage early diagnosis and treatment, increasing the demand for OVDs. The combination of a strong healthcare infrastructure and proactive government support creates a thriving market for ophthalmic viscoelastic devices in Japan.
Thus, the growth of the ophthalmic viscoelastic devices market in Japan is a complex interplay of technological advancements, demographic trends, disease epidemiology, healthcare infrastructure, market dynamics, and government support. While technological innovations and an upsurge in aging population drive market expansion, challenges such as high costs and competitive pressures pose significant obstacles. However, proactive government initiatives and robust healthcare infrastructure provide crucial support, fostering a conducive environment for the growth of the OVDs market in Japan.
Segmental Overview
The Japan ophthalmic viscoelastic devices market is segmented into product, application, and end user. On the basis of product, it is bifurcated into cohesive OVD and dispersive OVD. On the basis of application, the market is classified into cataract surgery, glaucoma surgery, corneal transplant, and vitreoretinal surgery. On the basis of end user, it is divided into hospitals, ophthalmic clinics, and others.
By Product
The cohesive OVD segment held the largest Japan ophthalmic viscoelastic devices market share in 2023. This growth is driven by its superior properties in maintaining space, protecting delicate eye tissues, and aiding surgical visualization during various ophthalmic procedures. Surgeons prefer cohesive OVDs for their ability to maintain a cohesive gel-like structure, minimizing tissue damage and ensuring optimal surgical outcomes. As a result, cohesive OVDs experienced significant growth, capturing the largest market share in Japan.
However, dispersive OVD is anticipated to register the highest CAGR during the forecast period owing to their specialized characteristics, including excellent tissue coating and endothelial cell protection during surgical procedures. Surgeons increasingly recognize the benefits of dispersive OVDs in complex surgeries like phacoemulsification and endothelial keratoplasty. Additionally, advancements in formulation and manufacturing processes, coupled with expanding applications in both anterior and posterior segment surgeries, are driving the surge in demand for dispersive OVDs, fueling their projected growth.
By Application
The cataract surgery segment held the largest Japan ophthalmic viscoelastic devices market share in 2023. This growth is driven by the high prevalence of cataracts and the consequent demand for cataract surgeries. Viscoelastic devices are crucial in maintaining intraocular pressure and facilitating surgical procedures, driving growth in this segment. Additionally, advancements in cataract surgery techniques and increasing awareness among patients further contributed to the segment's expansion.
By Application
Cataract Surgery segment held a dominant position in the market in 2023 and Glaucoma Surgery segment is anticipated to grow at a fastest rate during the forecast period.
However, glaucoma surgery is anticipated to register the highest CAGR during the forecast period owing to the increasing prevalence of glaucoma and the growing demand for surgical interventions to manage the condition effectively. Technological advancements in glaucoma surgery techniques, such as minimally invasive procedures and the development of novel devices, are also driving this trend, attracting both patients and healthcare providers towards this segment.
By End User
The hospitals segment held the largest Japan ophthalmic viscoelastic devices market share in 2023. This growth is driven by its extensive infrastructure and high surgical volume. Hospitals conduct numerous ophthalmic procedures, leading to increased demand for viscoelastic devices and driving growth in this segment.
By End User
Hospital segment held a dominant position in the market in 2023 and Ophthalmic Clinics segment is anticipated to grow at a fastest rate during the forecast period.
However, ophthalmic clinics is anticipated to register the highest CAGR during the forecast period owing to rising patient preference for outpatient procedures, technological advancements enabling minimally invasive surgeries, and the personalized care offered by specialized clinics, facilitating quicker access to services.
Competition Analysis
Competitive analysis and profiles of the major players in the Alcon Inc., Seikagaku Corporation, Johnson & Johnson, Baush+Lomb, Bohus BioTech AB, ZEISS Group, CIMA Product Inc, RUMEX International Co, Eyekon Medical and Rayner Group. Key players operating in the market have adopted various strategies such as acquisition, partnership, and collaboration as their key strategy to expand their product portfolio.
Recent Developments in Asia-Pacific Stroke Management Industry
- In April 2024, Carl Zeiss Meditec AG announced that after securing all required regulatory approvals, it has completed the acquisition of 100% of D.O.R.C. (Dutch Ophthalmic Research Center) from the investment firm Eurazeo SE, Paris, France. The acquisition enhances and complements ZEISS Medical Technology’s broad ophthalmic portfolio and range of digitally connected workflow solutions for addressing a wide variety of eye conditions, spanning retina and cornea disorders, cataract, glaucoma, and refractive errors.
Japan Ophthalmic Viscoelastic Devices Market Report Highlights
| Aspects | Details |
 By Product |
|
 By Application |
|
 By End User |
|
 Key Market Players | RUMEX International Co, Rayner Group., Eyekon Medical, ZEISS Group, Alcon Inc., CIMA Product Inc, Seikagaku Corporation, Bohus BioTech AB, Johnson & Johnson, Baush+Lomb |
Analyst Review
This section provides various opinions in the Japan ophthalmic Viscoelastic devices market. According to the insights of CXOs, rise in prevalence of eye related diseases boosts growth of the Japan ophthalmic viscoelastic devices market.
Furthermore, the technological advancements in these devices are further contributing to the market growth. They are widely used in surgeries for cataracts, glaucoma, vitreoretinal conditions, and corneal transplants. Cataracts, in particular, are highly common and are effectively treated with surgery if detected early, driving the use of various ophthalmic viscoelastic devices such as cohesive and dispersive types. In addition, the market growth is fueled by an aging population, higher disposable incomes, skilled ophthalmologists, and their preference for these devices in surgeries.
The total market value of North America Ophthalmic Viscoelastic Devices monitoring market is $0.18 billion in 2023.
The market value of Japan Ophthalmic Viscoelastic Devices Market in 2033 is $o.30billion.
The forecast period for Japan Ophthalmic Viscoelastic Devices Market is 2024 to 2033.
The base year is 2023 in Japan Ophthalmic Viscoelastic Devices Market.
Cataract surgery is accounted for the largest market share in 2023 owing to the high prevalence of cataracts, increased early diagnoses, and advancements in surgical techniques. In addition, the widespread adoption of ophthalmic viscoelastic devices in cataract surgeries enhances procedural outcomes, driving the segment's market dominance
Ophthalmic viscoelastic devices (OVDs) serve as indispensable tools in various eye surgeries, including those addressing cataracts, glaucoma, and corneal transplants. These visco-surgical devices are of important for ensuring optimal treatment outcomes and preventing further vision impairment or loss.
The growth of the Japan Ophthalmic Viscoelastic Devices Market is primarily driven by surge in the prevalence of ophthalmic diseases, rise in number of ophthalmic surgeries, rise in adoption of ophthalmic device.
Loading Table Of Content...
